New Zealand’s banking landscape faces significant changes as new players target different segments, potentially disrupting ...

New Zealand food manufacturers are beginning to embrace the circular economy but are up against a lack of government support, ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

GSK has licensed a small molecule for Parkinson's and is teaming up on additional targets for the disease and another ...

GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...

GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...

Enter: “Your Cancer Is Our Challenge,” a new initiative that GSK unveiled Tuesday with an aim of raising awareness of and ...

A biotech company has plans to begin offering a new type of treatment for some blood cancers, in Christchuch.

Pacific Trade Invest NZ invites you to an important webinar on the FMCG industry in New Zealand. This will be of great ...

The Mātai Medical Institute has already made waves with its MRI research, but if they have their way, this is just the beginning.

London stocks had extended gains by midday on Friday as investors digested a raft of UK data releases and looked ahead to the ...

This article explores the strengthening China-Singapore economic ties, highlighting potential opportunities in trade and investment.